Nadia Agopyan
General Counsel bei MARKER THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Profil
Nadia Agopyan is currently the Vice President-Regulatory Affairs at Marker Therapeutics, Inc. She previously worked as the Director-Regulatory Affairs at Janssen Oncology, Inc. and Kite Pharma, Inc. She also held positions as the Senior Director-Regulatory Affairs at Ambit Biosciences Corp.
and the Head-Global Regulatory Affairs at Baxter BioScience Corp.
Prior to her industry experience, she was an Assistant Professor at Duke University and the University of Toronto.
Dr. Agopyan obtained her undergraduate and doctorate degrees from McGill University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.02.2023 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Nadia Agopyan
| Unternehmen | Position | Beginn |
|---|---|---|
| MARKER THERAPEUTICS, INC. | General Counsel | 15.08.2019 |
Ehemalige bekannte Positionen von Nadia Agopyan
| Unternehmen | Position | Ende |
|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 01.08.2019 |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Corporate Officer/Principal | 01.04.2015 |
| AMBIT BIOSCIENCES CORP | General Counsel | 01.02.2012 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | Corporate Officer/Principal | 01.01.2003 |
| University of Toronto | Corporate Officer/Principal | 01.01.2000 |
Ausbildung von Nadia Agopyan
| McGill University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MARKER THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA. | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
